- 現金殖利率: 0.01%、總殖利率: 0.71%、5年平均現金配發率: 5.64%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 1.12 | 0 | 0.01 | 0 | 0.07 | 0 | 0.89 | 0 | 6.25 | 0 | 7.14 | 0 |
| 2022 (9) | -0.48 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2021 (8) | -1.21 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2020 (7) | -1.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2019 (6) | -1.06 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2018 (5) | 5.77 | 0 | 0.60 | 0 | 0.00 | 0 | 10.40 | 0 | 0.00 | 0 | 10.40 | 0 |
| 2017 (4) | -0.92 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2016 (3) | 0.19 | -69.84 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 0.21 | -79.61 | -43.24 | 0.54 | 5.88 | 260.0 | 1.10 | -39.89 | 10.0 |
| 24Q2 (19) | 1.03 | 30.38 | 83.93 | 0.51 | 45.71 | 131.82 | 1.83 | 131.65 | 190.48 |
| 24Q1 (18) | 0.79 | 139.39 | 1216.67 | 0.35 | 133.33 | 775.0 | 0.79 | -40.6 | 1216.67 |
| 23Q4 (17) | 0.33 | -10.81 | 151.56 | 0.15 | 0.0 | 193.75 | 1.33 | 33.0 | 377.08 |
| 23Q3 (16) | 0.37 | -33.93 | 294.74 | 0.15 | -31.82 | 215.38 | 1.00 | 58.73 | 525.0 |
| 23Q2 (15) | 0.56 | 833.33 | 833.33 | 0.22 | 450.0 | 0 | 0.63 | 950.0 | 80.0 |
| 23Q1 (14) | 0.06 | 109.38 | -80.0 | 0.04 | 125.0 | -63.64 | 0.06 | 112.5 | -80.0 |
| 22Q4 (13) | -0.64 | -236.84 | 5.88 | -0.16 | -23.08 | 23.81 | -0.48 | -400.0 | 60.33 |
| 22Q3 (12) | -0.19 | -416.67 | -18.75 | -0.13 | 0 | -225.0 | 0.16 | -54.29 | 129.09 |
| 22Q2 (11) | 0.06 | -80.0 | 130.0 | 0.00 | -100.0 | -100.0 | 0.35 | 16.67 | 189.74 |
| 22Q1 (10) | 0.30 | 144.12 | 250.0 | 0.11 | 152.38 | 466.67 | 0.30 | 124.79 | 250.0 |
| 21Q4 (9) | -0.68 | -325.0 | -78.95 | -0.21 | -425.0 | -162.5 | -1.21 | -120.0 | -21.0 |
| 21Q3 (8) | -0.16 | 20.0 | -420.0 | -0.04 | -500.0 | -500.0 | -0.55 | -41.03 | 9.84 |
| 21Q2 (7) | -0.20 | 0.0 | -42.86 | 0.01 | 133.33 | 133.33 | -0.39 | -95.0 | 41.79 |
| 21Q1 (6) | -0.20 | 47.37 | 62.26 | -0.03 | 62.5 | 80.0 | -0.20 | 80.0 | 62.26 |
| 20Q4 (5) | -0.38 | -860.0 | 29.63 | -0.08 | -900.0 | 0.0 | -1.00 | -63.93 | 5.66 |
| 20Q3 (4) | 0.05 | 135.71 | 0.0 | 0.01 | 133.33 | 0.0 | -0.61 | 8.96 | 0.0 |
| 20Q2 (3) | -0.14 | 73.58 | 0.0 | -0.03 | 80.0 | 0.0 | -0.67 | -26.42 | 0.0 |
| 20Q1 (2) | -0.53 | 1.85 | 0.0 | -0.15 | -87.5 | 0.0 | -0.53 | 50.0 | 0.0 |
| 19Q4 (1) | -0.54 | 0.0 | 0.0 | -0.08 | 0.0 | 0.0 | -1.06 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 1.36 | -12.05 | 88.14 | 11.89 | 50.01 | 3.98 | N/A | 主要係軟體收入較去年同期增加所致。 | ||
| 2024/9 | 1.54 | 42.09 | 77.09 | 10.53 | 46.19 | 3.52 | 0.22 | 主要係軟體收入較去年同期增加所致。 | ||
| 2024/8 | 1.08 | 21.59 | 18.11 | 8.99 | 41.95 | 3.25 | 0.24 | - | ||
| 2024/7 | 0.89 | -30.08 | 52.65 | 7.91 | 45.99 | 3.5 | 0.22 | 主要係拉鍊收入較去年同期增加所致 | ||
| 2024/6 | 1.28 | -4.56 | 85.59 | 7.02 | 45.18 | 3.97 | 0.21 | 主要係軟體收入較去年同期增加所致。 | ||
| 2024/5 | 1.34 | -1.32 | 18.21 | 5.74 | 38.48 | 3.89 | 0.22 | - | ||
| 2024/4 | 1.35 | 12.52 | 104.95 | 4.4 | 46.09 | 3.59 | 0.23 | 主係轉投資子公司113.04營收較去年同期增加所致 | ||
| 2024/3 | 1.2 | 16.51 | 10.74 | 3.05 | 29.55 | 3.05 | 0.29 | - | ||
| 2024/2 | 1.03 | 27.29 | 47.22 | 1.84 | 45.7 | 2.48 | 0.35 | - | ||
| 2024/1 | 0.81 | 27.81 | 43.81 | 0.81 | 43.81 | 2.5 | 0.35 | - | ||
| 2023/12 | 0.64 | -39.67 | 117.13 | 9.61 | 20.3 | 2.41 | 0.37 | 主係112年3月取得子公司營收併入所致。 | ||
| 2023/11 | 1.05 | 46.13 | 204.83 | 8.98 | 16.62 | 2.64 | 0.34 | 主係112年3月取得子公司營收併入所致。 | ||
| 2023/10 | 0.72 | -17.22 | 55.6 | 7.92 | 7.78 | 2.51 | 0.36 | 主係112年3月取得子公司營收併入所致。 | ||
| 2023/9 | 0.87 | -5.22 | 108.84 | 7.2 | 4.57 | 2.37 | 0.38 | 主係112年3月取得子公司營收併入所致。 | ||
| 2023/8 | 0.92 | 57.14 | 46.6 | 6.33 | -2.13 | 2.19 | 0.42 | - | ||
| 2023/7 | 0.58 | -14.99 | 5.47 | 5.42 | -7.35 | 2.4 | 0.38 | - | ||
| 2023/6 | 0.69 | -39.2 | -1.53 | 4.83 | -8.69 | 2.48 | 0.38 | - | ||
| 2023/5 | 1.13 | 71.07 | 24.99 | 4.14 | -9.78 | 2.88 | 0.32 | - | ||
| 2023/4 | 0.66 | -39.19 | 5.42 | 3.01 | -18.31 | 2.45 | 0.38 | - | ||
| 2023/3 | 1.09 | 54.88 | -12.27 | 2.35 | -23.17 | 2.35 | 0.44 | - | ||
| 2023/2 | 0.7 | 24.34 | 17.91 | 1.27 | -30.58 | 1.56 | 0.67 | - | ||
| 2023/1 | 0.56 | 92.96 | -54.07 | 0.56 | -54.07 | 1.2 | 0.87 | 主係本期銷售量較去年同期減少所致。 | ||
| 2022/12 | 0.29 | -15.3 | -61.55 | 7.99 | -15.21 | 1.1 | 1.16 | 主係本期銷售量較去年同期減少所致。 | ||
| 2022/11 | 0.35 | -25.4 | -51.88 | 7.7 | -11.14 | 1.22 | 1.05 | 主係本期銷售量較去年同期減少所致。 | ||
| 2022/10 | 0.46 | 11.1 | -9.89 | 7.35 | -7.46 | 1.51 | 0.85 | - | ||
| 2022/9 | 0.42 | -33.47 | -34.48 | 6.89 | -7.29 | 1.6 | 0.71 | - | ||
| 2022/8 | 0.63 | 13.06 | -5.83 | 6.47 | -4.75 | 1.88 | 0.61 | - | ||
| 2022/7 | 0.55 | -20.64 | -33.18 | 5.85 | -4.63 | 2.16 | 0.53 | - | ||
| 2022/6 | 0.7 | -22.83 | -15.86 | 5.29 | -0.16 | 2.23 | 0.54 | - | ||
| 2022/5 | 0.9 | 44.29 | -15.78 | 4.59 | 2.74 | 2.77 | 0.44 | - | ||
| 2022/4 | 0.63 | -49.4 | -44.88 | 3.69 | 8.6 | 2.46 | 0.49 | - | ||
| 2022/3 | 1.24 | 108.18 | 5.16 | 3.06 | 35.52 | 3.06 | 0.44 | - | ||
| 2022/2 | 0.6 | -51.56 | 25.49 | 1.82 | 68.58 | 2.58 | 0.52 | 因疫情影響, 客戶提早下單, 故營收較去年同期皆有大幅度的成長 | ||
| 2022/1 | 1.23 | 61.53 | 102.21 | 1.23 | 102.21 | 2.71 | 0.5 | 因疫情影響, 客戶提早下單, 故營收較去年同期皆有大幅度的成長 | ||
| 2021/12 | 0.76 | 5.99 | 90.7 | 9.42 | 18.4 | 1.99 | 0.7 | 因國際塞港問題嚴重, 客戶提早下單, 交期提早,故營收較去年同期成長幅度較大 | ||
| 2021/11 | 0.72 | 39.69 | 22.79 | 8.66 | 14.58 | 1.87 | 0.74 | - | ||
| 2021/10 | 0.51 | -19.22 | -12.97 | 7.94 | 13.9 | 1.81 | 0.77 | - | ||
| 2021/9 | 0.64 | -4.37 | -10.51 | 7.43 | 16.38 | 2.13 | 0.86 | - | ||
| 2021/8 | 0.67 | -19.77 | -8.38 | 6.8 | 19.75 | 2.32 | 0.79 | - | ||
| 2021/7 | 0.83 | -0.07 | -6.74 | 6.13 | 23.88 | 2.73 | 0.67 | - | ||
| 2021/6 | 0.83 | -22.75 | 116.48 | 5.3 | 30.59 | 3.04 | 0.66 | 去年同期調整銷售熔噴布/口罩收入改採淨額認列勞務收入 | ||
| 2021/5 | 1.07 | -5.56 | 18.21 | 4.47 | 21.63 | 3.39 | 0.59 | - | ||
| 2021/4 | 1.14 | -3.45 | 18.69 | 3.4 | 22.76 | 2.79 | 0.72 | - | ||
| 2021/3 | 1.18 | 148.43 | 29.46 | 2.26 | 24.91 | 2.26 | 1.03 | - | ||
| 2021/2 | 0.47 | -21.95 | -0.72 | 1.08 | 20.31 | 1.48 | 1.57 | - | ||
| 2021/1 | 0.61 | 52.34 | 44.16 | 0.61 | 44.16 | 1.59 | 1.46 | - | ||
| 2020/12 | 0.4 | -31.75 | -21.57 | 7.96 | -11.82 | 1.57 | 1.33 | - | ||
| 2020/11 | 0.58 | -0.99 | -6.72 | 7.56 | -11.24 | 1.89 | 1.11 | - | ||
| 2020/10 | 0.59 | -16.94 | -11.12 | 6.98 | -11.59 | 2.03 | 1.04 | - | ||
| 2020/9 | 0.71 | -2.1 | -1.38 | 6.38 | -11.64 | 2.33 | 0.93 | - | ||
| 2020/8 | 0.73 | -18.33 | -11.46 | 5.67 | -12.78 | 2.0 | 1.09 | - | ||
| 2020/7 | 0.89 | 131.96 | 43.02 | 4.95 | -12.96 | 2.18 | 1.0 | - | ||
| 2020/6 | 0.38 | -57.81 | -32.63 | 4.06 | -19.84 | 2.25 | 1.02 | - | ||
| 2020/5 | 0.91 | -5.18 | 1.82 | 3.68 | -18.22 | 2.78 | 0.83 | - | ||
| 2020/4 | 0.96 | 5.3 | -14.63 | 2.77 | -23.18 | 2.35 | 0.98 | - | ||
| 2020/3 | 0.91 | 90.5 | -23.9 | 1.81 | -27.06 | 1.81 | 1.45 | - | ||
| 2020/2 | 0.48 | 13.32 | -9.59 | 0.9 | -29.99 | 1.41 | 1.87 | - | ||
| 2020/1 | 0.42 | -17.11 | -44.25 | 0.42 | -44.25 | 1.56 | 1.69 | - | ||
| 2019/12 | 0.51 | -18.83 | 2.73 | 9.03 | -3.88 | 0.0 | N/A | - | ||
| 2019/11 | 0.63 | -5.65 | -5.19 | 8.52 | -4.25 | 0.0 | N/A | - |
